30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert Ford

Track

Insider profile

Currently holds a position at Abbott Laboratories

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 19% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Chief Operating Officer, Director Abbott Laboratories March 31, 2020 -
President, Chief Operating Officer Abbott Laboratories Oct. 15, 2018 - March 31, 2020
Executive Vice President - Medical Devices Abbott Laboratories Jan. 1, 2015 - Oct. 15, 2018
Senior Vice President - Diabetes Care. Abbott Laboratories Jan. 1, 2014 - Jan. 1, 2015
Robert Ford's trades of Abbott Laboratories's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-26 2026-01-23
B Purchase
30,344 -21.1%
168.85
US$790,832 		30,344 -21.1% 168.85 US$790,832
2025-02-07 2025-02-05
S Sale
99,653 -21.7%
389.13
US$1,762,219 		99,653 -21.7% 389.13 US$1,762,219
2025-02-05 2025-02-05
PrS Proposed sale
49,337
57.57
US$4,519,130 		49,337 57.57 US$4,519,130
2024-09-13 2024-09-12
S Sale
61,380 -21.8%
116.90
US$7,175,322 		61,380 -21.8% 116.90 US$7,175,322
2024-09-13 2024-09-12
S Sale
80,299 -22.2%
116.04
US$9,317,896 		80,299 -22.2% 116.04 US$9,317,896
2024-09-12 2024-09-12
PrS Proposed sale
141,679
116.41
US$16,492,852 		141,679 116.41 US$16,492,852
2022-08-26 2022-08-25
S Sale
102,425 -41.9%
105.10
US$10,765,154 		102,425 -41.9% 105.10 US$10,765,154